Latest KFF Health News Stories
Biden Seeks $400 Billion to Buttress Long-Term Care. A Look at What’s at Stake.
Long-term care options are expensive and often out of reach for seniors and people with disabilities. The president has proposed a massive infusion of federal funding for home and community-based health services that advocates say will go a long way toward helping individuals and families.
Fauci Thanks US Health Workers for Sacrifices but Admits PPE Shortages Drove Up Death Toll
Exclusive: The head of the National Institute of Allergy and Infectious Diseases says health workers ‘have lived up to the oath they take’ but says shortages of protective gear have contributed to excess deaths.
12 Months of Trauma: More Than 3,600 US Health Workers Died in Covid’s First Year
Lost on the Frontline, a yearlong investigation by The Guardian and KHN to count health care worker deaths, ends today. This is what we learned in a year of tracing the lives of those who made the ultimate sacrifice.
Calls Mount for Biden to Track US Health Care Worker Deaths from Covid
As The Guardian and KHN end Lost on the Frontline, a yearlong project to count health care worker deaths in the pandemic, the White House is under pressure to take up the task.
Lost on the Frontline: Explore the Database
As of Wednesday, the KHN-Guardian project counted 3,607 U.S. health worker deaths in the first year of the pandemic. Today we add 39 profiles, including a hospice chaplain, a nurse who spoke to intubated patients “like they were listening,” and a home health aide who couldn’t afford to stop working. This is the most comprehensive count in the nation as of April 2021, and our interactive database investigates the question: Did they have to die?
Para este enfermero de cuidados paliativos, la vacuna de covid llegó demasiado tarde
Cuando comenzó la pandemia, Antonio Espinoza, de 36 años, se dedicó a ayudar a los pacientes terminales. Hasta que él mismo cayó enfermo a cinco días de haberse dado la primera dosis de la vacuna contra covid.
For This Hospice Nurse, the Covid Shot Came Too Late
Antonio Espinoza, a hospice nurse in Southern California, ministered to terminally ill patients, including those with covid. He tested positive for covid five days after getting his first dose of vaccine and died a few weeks later.
Families With Sick Kids on Medicaid Seek Easier Access to Out-of-State Hospitals
Many state Medicaid programs pay out-of-state providers much less than in-state facilities, often making it hard for families with medically complex children to get the care they seek.
Despite Covid, Many Wealthy Hospitals Had a Banner Year With Federal Bailout
As the crisis crushed smaller providers, some of the nation’s richest health systems thrived, reporting hundreds of millions of dollars in surpluses after accepting huge grants for pandemic relief. But poorer hospitals — many serving rural and minority populations — got a smaller slice of the pie and limped through the year with deficits and a bleak fiscal future.
In California, Blue Shield’s Vaccination Takeover Fixes What Wasn’t Broken
Rural Mendocino County had finally figured out its vaccination program. But now the community clinics that helped make it happen are changing course as Blue Shield of California takes over the state vaccine program.
Medicamentos ya conocidos, y baratos, podrían ser clave para tratar covid
Hay medicamentos aprobados hace años que podrían investigarse en profundidad para tratar covid. Pero no hay interés porque no generarían grandes ganancias.
Scientists Seek Covid Treatment Answers in Cheap, Older Drugs
Philanthropies are funding studies of cheap, existing medications like the antidepressant fluvoxamine as covid treatments. But early hype about hydroxychloroquine and other repurposed drugs leaves researchers leery of hasty conclusions.
How Much of Trump’s Health Agenda Has Biden Undone?
In his campaign, President Joe Biden promised to undo policies, particularly health policies, implemented by former President Donald Trump. Yet, despite immense executive power, reversing four years of action takes time and resources.
Birx Joins Air-Cleaning Industry Amid Land Grab for Billions in Federal Covid Relief
Air-cleaning companies with limited oversight are targeting a growing market of schools desperate for covid-19 protection. Donald Trump’s former covid adviser lands with one that built its business, in part, on ozone-emitting technology.
El caso de la donación de vacunas contra covid estadounidenses al extranjero
Expertos felicitan las acciones de la administración Biden con las vacunas de covid, pero creen que en los próximos meses debería haber un enfoque global para que el mundo esté innmunizado.
Blue Shield Spent Years Cultivating a Relationship with Newsom. It Got the State Vaccine Contract.
Insurance giant Blue Shield of California has made millions in charitable and political donations to Gov. Gavin Newsom over nearly two decades, largely to his dearly held homeless initiatives. In turn, Newsom has rewarded the insurer with a $15 million no-bid contract to lead the state’s covid vaccination distribution.
The Case for Donating US Covid Vaccines Overseas
For now, there’s not enough vaccine for the U.S., but that could change within a few months. Vaccinating other nations will be key to stopping the pandemic – and keeping it away from our shores.
Doctors Debate Use of Blood Thinners to Prevent Clots in Women After C-Sections
One group of maternal health experts in 2016 urged doctors to give all women heparin shots after C-sections, barring specific medical risks for individual patients. But many physicians disagree, questioning whether wide use of the drug is effective, worth the cost and safe, since it carries the risk of bleeding.
Impulsan monitores de glucosa aunque no ayudarían a muchos pacientes con diabetes
Aunque algunos médicos y las aseguradoras dicen que son útiles, expertos aseguran que no ayudan a la mayoría de las personas que viven con diabetes tipo 2.
‘Painless’ Glucose Monitors Pushed Despite Little Evidence They Help Most Diabetes Patients
The numbers of people wearing these monitors are soaring as prices have fallen and device-makers promote them to doctors and patients. But few studies show the devices lead to better outcomes for the nearly 25 million Americans with Type 2 diabetes who don’t inject insulin to regulate their blood sugar.
